There's been a notable change in appetite for Myomo, Inc. (NYSEMKT:MYO) shares in the week since its quarterly report, with the stock down 14% to US$3.73. Revenues came in 25% better than analyst ...
Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb ...
Myomo (AMEX:MYO) is preparing to release its quarterly earnings on Monday, 2025-11-10. Here's a brief overview of what investors should keep in mind before the announcement. Analysts expect Myomo to ...
BOSTON--(BUSINESS WIRE)-- Myomo, Inc. (NYSE American: MYO) (“Myomo”), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper ...
Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb ...
Myomo's business model is now sustainable due to CMS reclassifying MyoPro, leading to lump sum payments and consistent insurance coverage. Medicare Part B coverage has significantly improved Myomo’s ...
4 analysts have expressed a variety of opinions on Myomo (AMEX:MYO) over the past quarter, offering a diverse set of opinions from bullish to bearish. The table below provides a concise overview of ...
BURLINGTON, Mass., March 02, 2026--(BUSINESS WIRE)--Myomo, Inc. (NYSE American: MYO) ("Myomo" or the "Company"), a wearable medical robotics company that offers increased functionality for those ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results